Specific VEGF sequestering and release using peptide-functionalized hydrogel microspheres

Biomaterials

Volumn 33, Issue 12, 2012, Pages 3475-3484

  Impellitteri, Nicholas A ^a   Toepke, Michael W ^a   Lan Levengood, Sheeny K ^a   Murphy, William L ^a,b  

^a University of Wisconsin Madison   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Bioinspired; Biomimetic; ECM; Extracellular matrix; Growth factors; Microparticle

Indexed keywords

BINDING AFFINITIES; BIO-INSPIRED; CELLULAR MICROENVIRONMENT; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX COMPONENTS; GENE EXPRESSION LEVELS; GROWTH FACTOR; GROWTH FACTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HYDROGEL MICROSPHERES; MICRO PARTICLES; NATIVE EXTRACELLULAR MATRIX; NEW STRATEGY; PEPTIDE LIGAND; TISSUE DEVELOPMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGFR-2;

BINDING ENERGY; BIOMIMETICS; GENE EXPRESSION; HYDROGELS; MILITARY ELECTRONIC COUNTERMEASURES; PEPTIDES; REPAIR; TISSUE;

MICROSPHERES;

GROWTH FACTOR; LIGAND; MICROSPHERE; PEPTIDE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CELL PROLIFERATION; DOWN REGULATION; HUMAN; HUMAN CELL; HYDROGEL; MICROENVIRONMENT; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; CATTLE; CELL PROLIFERATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEL; MICROSPHERES; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; SERUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857050203     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.01.032     Document Type: Article

References (28)

1. Tabata T., Takei Y. Morphogens, their identification and regulation 2004, vol. 131. Development, Cambridge, U.K, 703-712.
2. Plikus M.V., Mayer J.A., de la Cruz D., Baker R.E., Maini P.K., Maxson R., et al. Cyclic dermal BMP signalling regulates stem cell activation during hair regeneration. Nature (London) 2008, 451:340-348.
3. Mazzucco L., Borzini P., Gope R. Platelet-derived factors involved in tissue repair-from signal to function. Transfus Med Rev 2010, 24:218-234.
4. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249-257.
5. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676.
6. Kendall R.L., Thomas K.A. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993, 90:10705-10709.
7. Ebrahem Q., Chaurasia S.S., Vasanji A., Qi J.H., Klenotic P.A., Cutler A., et al. Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo. Am J Pathol 2010, 176:496-503.
8. Dvorak H.F., Brown L.F., Detmar M., Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995, 146:1029-1039.
9. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4-25.
10. Lopez P.F., Sippy B.D., Lambert H.M., Thach A.B., Hinton D.R. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996, 37:855-868.
11. Saint-Geniez M., Maharaj A.S.R., Walshe T.E., Tucker B.A., Sekiyama E., Kurihara T., et al. endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. Plos One 2008, 3:e3554.
12. Kamba T., Tam B.Y.Y., Hashizume H., Haskell A., Sennino B., Mancuso M.R., et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol-Heart C 2006, 290:H560-H576.
13. Wadman M. London's disastrous drug trial has serious side effects for research. Nature 2006, 440:388-389.
14. Sakiyama-Elbert S.E., Hubbell J.A. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 2000, 65:389-402.
15. Benoit D.S., Anseth K.S. Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. Acta Biomater 2005, 1:461-470.
16. Cushing M.C., Liao J.T., Jaeggli M.P., Anseth K.S. Material-based regulation of the myofibroblast phenotype. Biomaterials 2007, 28:3378-3387.
17. Nie T., Baldwin A., Yamaguchi N., Kiick K.L. Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems. J Control Release 2007, 122:287-296.
18. Hudalla G.A., Koepsel J.T., Murphy W.L. Surfaces that sequester serum-borne heparin amplify growth factor activity. Adv Mater 2011, 10.1002/adma.201103046.
19. Hudalla G.A., Kouris N.A., Koepsel J.T., Ogle B.M., Murphy W.L. Harnessing endogenous growth factor activity modulates stem cell behavior. Integr Biol (Camb) 2011, 3:832-842.
20. Piossek C., Thierauch K.H., Schneider-Mergener J., Volkmer-Engert R., Bachmann M.F., Korff T., et al. Potent inhibition of angiogenesis by D, L-peptides derived from vascular endothelial growth factor receptor 2. Thromb Haemostasis 2003, 90:501-510.
21. Goerges A.L., Nugent M.A. pH regulates vascular endothelial growth factor binding to fibronectin: a mechanism for control of extracellular matrix storage and release. J Biol Chem 2004, 279:2307-2315.
22. Wijelath E.S., Rahman S., Namekata M., Murray J., Nishimura T., Mostafavi-Pour Z., et al. Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res 2006, 99:853-860.
23. Kim S.H., Kiick K.L. Heparin-mimetic sulfated peptides with modulated affinities for heparin-binding peptides and growth factors. Peptides 2007, 28:2125-2136.
24. Maynard H.D., Hubbell J.A. Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor. Acta Biomater 2005, 1:451-459.
25. Hudalla G.A., Murphy W.L. Biomaterials that regulate growth factor activity via bioinspired interactions. Adv Funct Mater 2011, 21:1754-1768.
26. Chung H.J., Kim H.K., Yoon J.J., Park T.G. Heparin immobilized porous PLGA microspheres for angiogenic growth factor delivery. Pharm Res 2006, 8:1835-1841.
27. Willerth S.M., Johnson P.J., Maxwell D.J., Parsons S.R., Doukas M.E., Sakiyama-Elbert S.E. Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices. J Biomed Mater Res A 2007, 80:13-23.
28. Lin C.C., Metters A.T., Anseth K.S. Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha. Biomaterials 2009, 30:4907-4914.